nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—Pulmonary eosinophilia—Lisinopril—dilated cardiomyopathy	0.034	0.115	CcSEcCtD
Nedocromil—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0198	0.0675	CcSEcCtD
Nedocromil—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00944	0.0321	CcSEcCtD
Nedocromil—Otitis media—Lisinopril—dilated cardiomyopathy	0.00797	0.0271	CcSEcCtD
Nedocromil—Viral infection—Lisinopril—dilated cardiomyopathy	0.00687	0.0233	CcSEcCtD
Nedocromil—Cough increased—Lisinopril—dilated cardiomyopathy	0.00678	0.023	CcSEcCtD
Nedocromil—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00595	0.0202	CcSEcCtD
Nedocromil—Photophobia—Lisinopril—dilated cardiomyopathy	0.00582	0.0198	CcSEcCtD
Nedocromil—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00542	0.0184	CcSEcCtD
Nedocromil—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00514	0.0175	CcSEcCtD
Nedocromil—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00508	0.0173	CcSEcCtD
Nedocromil—Eczema—Lisinopril—dilated cardiomyopathy	0.00501	0.017	CcSEcCtD
Nedocromil—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00494	0.0168	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00468	0.0159	CcSEcCtD
Nedocromil—Arthritis—Lisinopril—dilated cardiomyopathy	0.00463	0.0158	CcSEcCtD
Nedocromil—Urticaria—Spironolactone—dilated cardiomyopathy	0.00431	0.0146	CcSEcCtD
Nedocromil—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00429	0.0146	CcSEcCtD
Nedocromil—Visual impairment—Furosemide—dilated cardiomyopathy	0.004	0.0136	CcSEcCtD
Nedocromil—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00399	0.0136	CcSEcCtD
Nedocromil—Influenza—Lisinopril—dilated cardiomyopathy	0.00389	0.0132	CcSEcCtD
Nedocromil—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00385	0.0131	CcSEcCtD
Nedocromil—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00374	0.0127	CcSEcCtD
Nedocromil—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00371	0.0126	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00362	0.0123	CcSEcCtD
Nedocromil—Dizziness—Spironolactone—dilated cardiomyopathy	0.00358	0.0122	CcSEcCtD
Nedocromil—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00354	0.012	CcSEcCtD
Nedocromil—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00349	0.0119	CcSEcCtD
Nedocromil—Vomiting—Spironolactone—dilated cardiomyopathy	0.00345	0.0117	CcSEcCtD
Nedocromil—Rash—Spironolactone—dilated cardiomyopathy	0.00342	0.0116	CcSEcCtD
Nedocromil—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00341	0.0116	CcSEcCtD
Nedocromil—Headache—Spironolactone—dilated cardiomyopathy	0.0034	0.0115	CcSEcCtD
Nedocromil—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00326	0.0111	CcSEcCtD
Nedocromil—Leukopenia—Furosemide—dilated cardiomyopathy	0.00323	0.011	CcSEcCtD
Nedocromil—Nausea—Spironolactone—dilated cardiomyopathy	0.00322	0.0109	CcSEcCtD
Nedocromil—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00312	0.0106	CcSEcCtD
Nedocromil—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00309	0.0105	CcSEcCtD
Nedocromil—Dry mouth—Furosemide—dilated cardiomyopathy	0.00301	0.0102	CcSEcCtD
Nedocromil—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00295	0.01	CcSEcCtD
Nedocromil—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00266	0.00903	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00255	0.00866	CcSEcCtD
Nedocromil—Fatigue—Furosemide—dilated cardiomyopathy	0.00254	0.00865	CcSEcCtD
Nedocromil—Tremor—Lisinopril—dilated cardiomyopathy	0.00254	0.00864	CcSEcCtD
Nedocromil—Pain—Furosemide—dilated cardiomyopathy	0.00252	0.00857	CcSEcCtD
Nedocromil—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00243	0.00825	CcSEcCtD
Nedocromil—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00241	0.0082	CcSEcCtD
Nedocromil—Cough—Lisinopril—dilated cardiomyopathy	0.00237	0.00804	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00235	0.00333	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00235	0.00333	CbGpPWpGaD
Nedocromil—Urticaria—Furosemide—dilated cardiomyopathy	0.00234	0.00797	CcSEcCtD
Nedocromil—FPR1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00234	0.00332	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00234	0.00332	CbGpPWpGaD
Nedocromil—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00233	0.00793	CcSEcCtD
Nedocromil—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00233	0.00793	CcSEcCtD
Nedocromil—Chest pain—Lisinopril—dilated cardiomyopathy	0.00231	0.00785	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00228	0.00323	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00226	0.0032	CbGpPWpGaD
Nedocromil—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00226	0.00768	CcSEcCtD
Nedocromil—CYSLTR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00222	0.00315	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00221	0.00752	CcSEcCtD
Nedocromil—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00217	0.00739	CcSEcCtD
Nedocromil—HSP90AA1—Fcgamma receptor (FCGR) dependent phagocytosis—RAC1—dilated cardiomyopathy	0.00217	0.00307	CbGpPWpGaD
Nedocromil—CYSLTR2—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00213	0.00302	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TUBB—dilated cardiomyopathy	0.00212	0.003	CbGpPWpGaD
Nedocromil—Asthenia—Furosemide—dilated cardiomyopathy	0.00212	0.00719	CcSEcCtD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00211	0.00299	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0021	0.00297	CbGpPWpGaD
Nedocromil—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00202	0.00686	CcSEcCtD
Nedocromil—FPR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00202	0.00286	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00201	0.00284	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00199	0.00281	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00199	0.00281	CbGpPWpGaD
Nedocromil—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00197	0.00671	CcSEcCtD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00196	0.00278	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.00196	0.00277	CbGpPWpGaD
Nedocromil—Dizziness—Furosemide—dilated cardiomyopathy	0.00195	0.00663	CcSEcCtD
Nedocromil—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00195	0.00662	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00195	0.00276	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.00192	0.00273	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00191	0.00271	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00191	0.0065	CcSEcCtD
Nedocromil—Fatigue—Lisinopril—dilated cardiomyopathy	0.00191	0.00649	CcSEcCtD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00191	0.0027	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.0019	0.0027	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0019	0.00269	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TUBB—dilated cardiomyopathy	0.00189	0.00268	CbGpPWpGaD
Nedocromil—Pain—Lisinopril—dilated cardiomyopathy	0.00189	0.00643	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—EMD—dilated cardiomyopathy	0.00189	0.00268	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00188	0.00266	CbGpPWpGaD
Nedocromil—Vomiting—Furosemide—dilated cardiomyopathy	0.00188	0.00638	CcSEcCtD
Nedocromil—FPR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00186	0.00264	CbGpPWpGaD
Nedocromil—Rash—Furosemide—dilated cardiomyopathy	0.00186	0.00632	CcSEcCtD
Nedocromil—Dermatitis—Furosemide—dilated cardiomyopathy	0.00186	0.00632	CcSEcCtD
Nedocromil—Headache—Furosemide—dilated cardiomyopathy	0.00185	0.00628	CcSEcCtD
Nedocromil—PTGDR—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00185	0.00262	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00185	0.00262	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00181	0.00615	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00181	0.00256	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00181	0.00256	CbGpPWpGaD
Nedocromil—PTGDR—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0018	0.00255	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00179	0.00253	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—ALMS1—dilated cardiomyopathy	0.00178	0.00252	CbGpPWpGaD
Nedocromil—Urticaria—Lisinopril—dilated cardiomyopathy	0.00176	0.00598	CcSEcCtD
Nedocromil—Nausea—Furosemide—dilated cardiomyopathy	0.00175	0.00596	CcSEcCtD
Nedocromil—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00175	0.00595	CcSEcCtD
Nedocromil—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00175	0.00595	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.00173	0.00246	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—EMD—dilated cardiomyopathy	0.00169	0.00239	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00168	0.00238	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.00165	0.00234	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.00164	0.00232	CbGpPWpGaD
Nedocromil—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00163	0.00554	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00163	0.00231	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00162	0.0023	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—ALMS1—dilated cardiomyopathy	0.00159	0.00225	CbGpPWpGaD
Nedocromil—Asthenia—Lisinopril—dilated cardiomyopathy	0.00159	0.0054	CcSEcCtD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00155	0.0022	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.00155	0.0022	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00154	0.00218	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00153	0.00216	CbGpPWpGaD
Nedocromil—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00151	0.00515	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00148	0.0021	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00148	0.0021	CbGpPWpGaD
Nedocromil—CYSLTR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00148	0.00209	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00148	0.00209	CbGpPWpGaD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00148	0.00209	CbGpPWpGaD
Nedocromil—Dizziness—Lisinopril—dilated cardiomyopathy	0.00146	0.00498	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00145	0.00205	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00143	0.00203	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00143	0.00203	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—PSEN2—dilated cardiomyopathy	0.00142	0.00201	CbGpPWpGaD
Nedocromil—FPR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00142	0.00201	CbGpPWpGaD
Nedocromil—CYSLTR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00141	0.002	CbGpPWpGaD
Nedocromil—Vomiting—Lisinopril—dilated cardiomyopathy	0.00141	0.00478	CcSEcCtD
Nedocromil—Rash—Lisinopril—dilated cardiomyopathy	0.0014	0.00474	CcSEcCtD
Nedocromil—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00139	0.00474	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00139	0.00197	CbGpPWpGaD
Nedocromil—Headache—Lisinopril—dilated cardiomyopathy	0.00139	0.00471	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00138	0.00195	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00138	0.00195	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00138	0.00195	CbGpPWpGaD
Nedocromil—PTGDR—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00137	0.00194	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00135	0.00191	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00135	0.00191	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00133	0.00189	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00133	0.00188	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00132	0.00187	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00132	0.00187	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00132	0.00187	CbGpPWpGaD
Nedocromil—Nausea—Lisinopril—dilated cardiomyopathy	0.00131	0.00447	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0013	0.00184	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0013	0.00184	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.0013	0.00184	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.0013	0.00184	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00129	0.00183	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00128	0.00181	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00125	0.00177	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00124	0.00176	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00121	0.00172	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00121	0.00171	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00117	0.00166	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.00115	0.00163	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00114	0.00161	CbGpPWpGaD
Nedocromil—HSP90AA1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.00113	0.00161	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—TMPO—dilated cardiomyopathy	0.00112	0.00159	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00112	0.00159	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00112	0.00159	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.0011	0.00156	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.00109	0.00154	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00108	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00108	0.00152	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00106	0.0015	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00104	0.00148	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00104	0.00148	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00103	0.00147	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00102	0.00144	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00102	0.00144	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00101	0.00144	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00101	0.00143	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.001	0.00142	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TMPO—dilated cardiomyopathy	0.001	0.00142	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000999	0.00142	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000981	0.00139	CbGpPWpGaD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000979	0.00139	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000962	0.00136	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000957	0.00136	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000948	0.00134	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000948	0.00134	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000922	0.00131	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000918	0.0013	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000918	0.0013	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000917	0.0013	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000907	0.00129	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TAZ—dilated cardiomyopathy	0.0009	0.00128	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000895	0.00127	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ITGB1—dilated cardiomyopathy	0.00089	0.00126	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000864	0.00122	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000863	0.00122	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000848	0.0012	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000839	0.00119	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—LMNA—dilated cardiomyopathy	0.000825	0.00117	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000822	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000819	0.00116	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SDHA—dilated cardiomyopathy	0.000814	0.00115	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00081	0.00115	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000802	0.00114	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000795	0.00113	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000795	0.00113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000784	0.00111	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000778	0.0011	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000778	0.0011	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000774	0.0011	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000768	0.00109	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000768	0.00109	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000762	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000755	0.00107	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000745	0.00106	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000744	0.00105	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000739	0.00105	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000736	0.00104	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000728	0.00103	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000723	0.00102	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000716	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—RAC1—dilated cardiomyopathy	0.000715	0.00101	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000714	0.00101	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000707	0.001	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000707	0.001	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000703	0.000996	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000701	0.000993	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000691	0.000979	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000678	0.000961	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000657	0.000931	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000636	0.000901	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000636	0.000901	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000635	0.000899	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000629	0.000891	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000611	0.000866	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000608	0.000861	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000602	0.000853	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000602	0.000853	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000598	0.000848	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00059	0.000836	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00058	0.000821	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000577	0.000818	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000568	0.000804	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000563	0.000798	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00056	0.000793	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00056	0.000793	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000552	0.000782	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000543	0.00077	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000542	0.000768	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CD36—dilated cardiomyopathy	0.000541	0.000767	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000518	0.000734	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000516	0.00073	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—RAC1—dilated cardiomyopathy	0.00051	0.000723	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000505	0.000716	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000498	0.000706	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NPPA—dilated cardiomyopathy	0.000498	0.000705	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000488	0.000691	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PSEN2—dilated cardiomyopathy	0.000482	0.000683	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000481	0.000682	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD36—dilated cardiomyopathy	0.000478	0.000678	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—RAF1—dilated cardiomyopathy	0.000474	0.000672	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00047	0.000666	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000463	0.000656	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—RAC1—dilated cardiomyopathy	0.000451	0.000638	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00045	0.000638	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000441	0.000624	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000439	0.000622	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000435	0.000616	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00043	0.000609	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000421	0.000597	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000417	0.000591	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000417	0.000591	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AGT—dilated cardiomyopathy	0.000415	0.000588	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.0004	0.000567	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000388	0.00055	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000383	0.000542	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000382	0.000542	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000378	0.000535	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000376	0.000532	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000346	0.000491	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000341	0.000483	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—RAF1—dilated cardiomyopathy	0.000338	0.000479	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000337	0.000478	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000335	0.000474	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ITGB1—dilated cardiomyopathy	0.000327	0.000463	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000326	0.000462	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—dilated cardiomyopathy	0.000325	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000321	0.000455	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000305	0.000431	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.0003	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.0003	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—RAF1—dilated cardiomyopathy	0.000299	0.000423	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000298	0.000423	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000288	0.000408	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000279	0.000395	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CD36—dilated cardiomyopathy	0.000279	0.000395	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00027	0.000382	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000265	0.000376	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000263	0.000372	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAC1—dilated cardiomyopathy	0.000262	0.000372	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000262	0.000371	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RAC1—dilated cardiomyopathy	0.000242	0.000343	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000236	0.000335	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—dilated cardiomyopathy	0.000232	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00023	0.000326	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000226	0.00032	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000226	0.00032	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GPX1—dilated cardiomyopathy	0.000221	0.000313	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TNF—dilated cardiomyopathy	0.000221	0.000313	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000219	0.00031	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CD36—dilated cardiomyopathy	0.000215	0.000305	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—dilated cardiomyopathy	0.000205	0.00029	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000205	0.00029	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000198	0.00028	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AGT—dilated cardiomyopathy	0.000194	0.000275	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000188	0.000266	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000182	0.000258	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RAF1—dilated cardiomyopathy	0.000174	0.000247	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00017	0.00024	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000162	0.00023	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—RAF1—dilated cardiomyopathy	0.000161	0.000228	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000157	0.000222	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000155	0.00022	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—dilated cardiomyopathy	0.000119	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000113	0.000159	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—dilated cardiomyopathy	0.00011	0.000156	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000108	0.000152	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.72e-05	0.000109	CbGpPWpGaD
